Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Roche Products Ltd. Please contact Roche Drug Safety Centre by emailing welwyn.uk_dsc@roche.com or calling +44 (0)1707 367554.
Downloads
This report is intended to be viewed online in your web browser.
Should you require additional information on topics presented at the NG:BC meeting, please click here
to contact us.
Sign in or register
To learn more about Roche products or meetings and congresses, please sign in or click here to register.
Access information, news and resources about our medicines and the therapy areas in which they are used
Next Generation: Breast Cancer 2021 Meeting Highlights
The third Next Generation: Breast Cancer (NG:BC) meeting took place on 14th–15th October 2021 and was Co-Chaired by Mr Henry Cain and Mr Robert Thomas (Consultant Oncoplastic Breast Surgeons; Royal Victoria Infirmary, Newcastle). The meeting was aimed at senior Specialist Registrars and early Consultants from across medical disciplines, including oncology, surgery, radiology and pathology. The meeting objective was to support colleagues in developing their breadth of knowledge, providing learnings applicable to their daily practice and patient care, as well as growing their network of peers.
Presentations from the expert faculty covered the latest data shaping practice across radiology, pathology, surgery, oncology and radiotherapy, followed by an MDT panel discussion. An overview of the plenary sessions is provided in the NG:BC 2021 Highlights Report.
Reference:
- Roche. Data on File. 2021
M-GB-00005306
Date of preparation: November 2021